159 related articles for article (PubMed ID: 7921613)
1. The effect of 5-HT1A receptor agonists on locomotor activity in the guinea-pig.
Evenden JL
Br J Pharmacol; 1994 Jul; 112(3):861-6. PubMed ID: 7921613
[TBL] [Abstract][Full Text] [Related]
2. GR46611 potentiates 5-HT1A receptor-mediated locomotor activity in the guinea pig.
O'Neill MF; Sanger GJ
Eur J Pharmacol; 1999 Apr; 370(2):85-92. PubMed ID: 10323255
[TBL] [Abstract][Full Text] [Related]
3. Effects of buspirone and ipsapirone on schedule induced polydipsia: comparison with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and raclopride.
Ryan CN; Evenden JL; Petterson M
Psychopharmacology (Berl); 1993; 112(1):34-44. PubMed ID: 7871008
[TBL] [Abstract][Full Text] [Related]
4. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
[TBL] [Abstract][Full Text] [Related]
5. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
Darmani NA; Reeves SL
Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
[TBL] [Abstract][Full Text] [Related]
7. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
[TBL] [Abstract][Full Text] [Related]
8. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM
Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851
[TBL] [Abstract][Full Text] [Related]
9. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
10. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
Clarke RW; Ogilvie J; Houghton AK
Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study.
Hadrava V; Blier P; Dennis T; Ortemann C; de Montigny C
Neuropharmacology; 1995 Oct; 34(10):1311-26. PubMed ID: 8570029
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonic vocalizations in rat pups: effects of serotonergic ligands.
Olivier B; Molewijk HE; van der Heyden JA; van Oorschot R; Ronken E; Mos J; Miczek KA
Neurosci Biobehav Rev; 1998; 23(2):215-27. PubMed ID: 9884114
[TBL] [Abstract][Full Text] [Related]
13. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
[TBL] [Abstract][Full Text] [Related]
14. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
Protais P; Lesourd M; Comoy E
Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
[TBL] [Abstract][Full Text] [Related]
15. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
[TBL] [Abstract][Full Text] [Related]
16. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
Kalkman HO; Soar J
Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
[TBL] [Abstract][Full Text] [Related]
17. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin on the cholinergic contraction in guinea pig and human airways in vitro.
Dupont LJ; Pype JL; Demedts MG; De Leyn P; Deneffe G; Verleden GM
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1479-86. PubMed ID: 9817696
[TBL] [Abstract][Full Text] [Related]
18. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
Schreiber R; De Vry J
Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
[TBL] [Abstract][Full Text] [Related]
19. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze.
Kõks S; Beljajev S; Koovit I; Abramov U; Bourin M; Vasar E
Psychopharmacology (Berl); 2001 Jan; 153(3):365-72. PubMed ID: 11271409
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
